Hunter-based biotech team ImmVirX working to develop cutting-edge cancer therapies

Updated January 22 2020 - 5:01pm, first published 4:56pm
Professor Darren Shafren of ImmVirX and the University of Newcastle. Picture: University of Newcastle
Professor Darren Shafren of ImmVirX and the University of Newcastle. Picture: University of Newcastle

Hunter-based biotech team ImmVirX is working on a private venture aiming to develop cutting-edge cancer therapies.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Newcastle news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.